Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Sep 4, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on understanding different types of neurovascular diseases, which can lead to serious conditions like ischemic strokes (caused by blocked blood flow) and hemorrhagic strokes (caused by bleeding in the brain). While common causes like atherosclerosis are well-researched, less common conditions, such as arterial dissections (tears in the blood vessels) and cerebral angiopathies (problems with blood vessel structure), need more study. The researchers want to gather long-term information about how patients recover after these events, using data collected from patients treated at the Lariboisière neurovascular intensive care unit.

To participate in this trial, individuals must be at least 18 years old and admitted to the neurovascular intensive care unit with acute cerebrovascular issues, such as a stroke. It’s important that patients agree to participate, and for those who may not be able to give consent themselves, their legal representatives can help. The trial is not yet recruiting participants, but once it starts, those who qualify can expect to contribute to valuable research that may improve understanding and treatment of these serious conditions in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Adult patients ≥18 years
• • 2. Patients admitted to the Neurovascular Intensive Care Unit with acute cerebrovascular disease OR Patients managed for acute cerebrovascular pathology with or without stroke by the Lariboisière neurology team.
• • 3. No opposition from the patient to the research and for patients under guardianship or guardianship or lack of capacity to object (severe impairment of cognitive functions, dementia, etc.), no opposition from the legal representative.
• Exclusion Criteria:
• • 1. Patient refusing to take part in the study or refusal by the legal representative in the case of patients under guardianship or curatorship
• • 2. Patient suffering from a rare neurovascular disease and being followed at the "Centre de référence des maladies vasculaires rares du cerveau et de l'oeil" (CERVCO)